Storz & Bickel® delivered its best Q4 revenue quarter, with net revenue increasing 43% as compared to Q4 2023 Canada medical cannabis net revenue increased 16% in Q4 FY2024 and 10% in FY2024 year-over-year Canada cannabis Cost of Goods Sold decreased by 54% in FY2024 versus FY2023 Following recent balance sheet actions, the Company has no material debt obligation due until March 20261 SMITHS FALLS, ON, May 30, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy", "Canopy Growth" or the "Company") (TSX: W ...